BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 25919235)

  • 21. Ovarian stimulation in the luteal phase: systematic review and meta-analysis.
    Boots CE; Meister M; Cooper AR; Hardi A; Jungheim ES
    J Assist Reprod Genet; 2016 Aug; 33(8):971-80. PubMed ID: 27146151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Random-start controlled ovarian stimulation for emergency fertility preservation in a patient with myelodysplastic syndrome: a case report.
    Cai H; Shen H
    Braz J Med Biol Res; 2016; 49(6):e5227. PubMed ID: 27191608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of letrozole on moderate and severe early-onset ovarian hyperstimulation syndrome in high-risk women: a prospective randomized trial.
    Mai Q; Hu X; Yang G; Luo Y; Huang K; Yuan Y; Zhou C
    Am J Obstet Gynecol; 2017 Jan; 216(1):42.e1-42.e10. PubMed ID: 27555316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ovarian response after random-start controlled ovarian stimulation to cryopreserve oocytes in cancer patients.
    Campos APC; Geber GP; Hurtado R; Sampaio M; Geber S
    JBRA Assist Reprod; 2018 Nov; 22(4):352-354. PubMed ID: 30264947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol.
    Hohmann FP; Macklon NS; Fauser BC
    J Clin Endocrinol Metab; 2003 Jan; 88(1):166-73. PubMed ID: 12519847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immature oocyte retrieval and in vitro oocyte maturation at different phases of the menstrual cycle in women with cancer who require urgent gonadotoxic treatment.
    Creux H; Monnier P; Son WY; Tulandi T; Buckett W
    Fertil Steril; 2017 Jan; 107(1):198-204. PubMed ID: 27810160
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Random-start ovarian stimulation in women desiring elective cryopreservation of oocytes.
    Pereira N; Voskuilen-Gonzalez A; Hancock K; Lekovich JP; Schattman GL; Rosenwaks Z
    Reprod Biomed Online; 2017 Oct; 35(4):400-406. PubMed ID: 28647355
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Double stimulations during the follicular and luteal phases of poor responders in IVF/ICSI programmes (Shanghai protocol).
    Kuang Y; Chen Q; Hong Q; Lyu Q; Ai A; Fu Y; Shoham Z
    Reprod Biomed Online; 2014 Dec; 29(6):684-91. PubMed ID: 25444501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Luteal phase stimulation, the future of fertility preservation? Retrospective cohort study of luteal phase versus follicular phase stimulation.
    Jochum F; Sananès N; Teletin M; Lichtblau I; Rongières C; Pirrello O
    J Gynecol Obstet Hum Reprod; 2019 Feb; 48(2):91-94. PubMed ID: 30439518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Usefulness of random-start progestin-primed ovarian stimulation for fertility preservation.
    Huang H; Itaya Y; Samejima K; Ichinose S; Narita T; Matsunaga S; Saitoh M; Takai Y
    J Ovarian Res; 2022 Jan; 15(1):2. PubMed ID: 34983605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fertility preservation with ovarian stimulation protocols prior to cancer treatment.
    Kasum M; Šimunić V; Orešković S; Beketić-Orešković L
    Gynecol Endocrinol; 2014 Mar; 30(3):182-6. PubMed ID: 24256369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of aromatase inhibitor on controlled ovarian stimulation for oocyte cryopreservation in adolescent and young cancer patients.
    Suzuki R; Horage-Okutsu Y; Kawahara T; Nakamura K; Shiraishi E; Iwahata H; Suzuki-Takahashi Y; Sugishita Y; Takae S; Suzuki N
    J Obstet Gynaecol Res; 2023 Mar; 49(3):973-979. PubMed ID: 36606606
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of starting ovarian stimulation on day 2 versus day 15 of the menstrual cycle in the same oocyte donor and pregnancy rates among the corresponding recipients of vitrified oocytes.
    Martínez F; Clua E; Devesa M; Rodríguez I; Arroyo G; González C; Solé M; Tur R; Coroleu B; Barri PN
    Fertil Steril; 2014 Nov; 102(5):1307-11. PubMed ID: 25154677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stimulation of the ovaries in women with breast cancer undergoing fertility preservation: Alternative versus standard stimulation protocols; the study protocol of the STIM-trial.
    Dahhan T; Balkenende EME; Beerendonk CCM; Fleischer K; Stoop D; Bos AME; Lambalk CB; Schats R; van Golde RJT; Schipper I; Louwé LA; Cantineau AEP; Smeenk JMJ; de Bruin JP; Reddy N; Kopeika Y; van der Veen F; van Wely M; Linn SC; Goddijn M
    Contemp Clin Trials; 2017 Oct; 61():96-100. PubMed ID: 28710053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Back-to-back random-start ovarian stimulation prior to chemotherapy to maximize oocyte yield.
    Wald K; Cakmak H; Mok-Lin E; Cedars M; Rosen M; Letourneau J
    J Assist Reprod Genet; 2019 Jun; 36(6):1161-1168. PubMed ID: 31127475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Specific protocols of controlled ovarian stimulation for oocyte cryopreservation in breast cancer patients.
    Cavagna F; Pontes A; Cavagna M; Dzik A; Donadio NF; Portela R; Nagai MT; Gebrim LH
    Curr Oncol; 2018 Dec; 25(6):e527-e532. PubMed ID: 30607119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro maturation of human immature oocytes for fertility preservation.
    Chian RC; Uzelac PS; Nargund G
    Fertil Steril; 2013 Apr; 99(5):1173-81. PubMed ID: 23433515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The case for aromatase inhibitors use in oncofertility patients. Should aromatase inhibitors be combined with gonadotropin treatment in breast cancer patients undergoing ovarian stimulation for fertility preservation prior to chemotherapy? A debate.
    Fatum M; McVeigh E; Child T
    Hum Fertil (Camb); 2013 Dec; 16(4):235-40. PubMed ID: 23863119
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Follicular steroidogenesis in random start protocols for oocyte cryopreservation.
    Galati G; Somigliana E; Ciaffaglione M; Reschini M; Serra N; Sanzani E; Viganò P; Polledri E; Fustinoni S; Muzii L; Filippi F
    J Assist Reprod Genet; 2023 Sep; 40(9):2149-2156. PubMed ID: 37439869
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of cancer on ovarian response in controlled ovarian stimulation for fertility preservation.
    Almog B; Azem F; Gordon D; Pauzner D; Amit A; Barkan G; Levin I
    Fertil Steril; 2012 Oct; 98(4):957-60. PubMed ID: 22763097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.